Global $45 Bn Autoimmune Disease Treatment Market, 2022

News provided by

Sep 21, 2017, 15:00 ET

DUBLIN, September 21, 2017 /PRNewswire/ --

The "Global Autoimmune Disease Treatment Market - By Disease Type, Diagonostics, Products, Region - Market Size, Demand Forecasts, Industry Trends and Updates (2016-2022)" report has been added to Research and Markets' offering.

Global autoimmune diseases treatment market is estimated to grow at a CAGR of 3.80% for the forecasted period, and its market value is expected to reach $45.54 billion by 2022 from $36.41 billion in 2016

Autoimmune diseases occur when the immune system of an individual's body treats healthy cells of his/her very own body as foreign cells and attacks them. These diseases causes variations in organ functioning, abnormal growth of organs and destruction of healthy body tissues. Autoimmune diseases are mostly chronic in nature and there is no curative therapy., Dermatomyositis, Type 1 diabetes Hashimoto's disease, Sjogren's syndrome, Psoriasis are some of the examples of Autoimmune diseases. Systemic autoimmune diseases treatment and Localized autoimmune disease treatment are two types of autoimmune disease treatment.

Various types of treatments for these diseases include Physical therapy, blood transfusion, Recombinant technology, Chemo therapy, Topical therapy, TNF-a antagonists and Helminthic therapy. Women, generally, have higher incidences of these diseases compared to men.

Dominance of North America and Europe in autoimmune disease market can be attributed to factors like prevalence of autoimmune diseases, increasing investments in R&D and higher disposable income in these regions. Factors such as improving health infrastructure, increasing awareness among people about heath care and increasing aging populations are going to fuel the rapid growth of autoimmune disease treatment market in Asia-Pacific region in the next five years.

Availability of various biosimilar drugs, Government initiatives and support to restrict autoimmune diseases are also major factors contributing for the growth of this market. Lack of standardized treatment for these diseases, Poorly trained physicians, low medical insurance coverage and low levels of awareness among public about these diseases are some of the challenges for this industry.

This industry comprises price based intense competition among various players. Some of the major players operating in autoimmune disease treatment market include Abott Laboratories, Roche, Johnson&Johnson, Beckman Coulter Inc., Pfizer, Lupin Limited and GlaxoSmithKline plc.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Market Overview

Definition
Value Chain Analysis
Porter's 5 Forces
Regulations

4. Market Dynamics

Introduction
Drivers
Constraints
Opportunities

5. Global Autoimmune Disease Treatment Market Segmentation, Forecasts and Trends - By Revenue

6. By Disease type

Localized
Systemic

7. By Diagonostics

IFA
ELISA
Dot blot
Line blot
Aggultination
Double immune diffusion
Western Blotting
Multiplex immunoassay
Others

8. By Products

Drugs
Therapeutic and monitoring equipment
Diagonostic equipments

9. By Region

North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia
Switzerland
Others
Asia-Pacific
China
India
Japan
Australia
Others
Latin America
Mexico
Brazil
Argentina
Others
MEA
UAE
Saudi Arabia
South Africa
Others

10. Vendor Market Share Analysis

11. Company Profiles

Abbott Laboratories
Active Biotech
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
Pfizer
Biogen Idec
Lupin Limited
GlaxoSmithKline
Amgen
4SC AG
F. Hoffmann-La Roche Ltd.
AutoImmune Inc
Johnson & Johnson
Bayer
Others

12. Industry Structure

Industry M&As, Consolidations
Investment Opportunities

13. Global Autoimmune Disease Treatment market - Road Ahead

Tables
Disclaimer

For more information about this report visit https://www.researchandmarkets.com/research/389pn9/global_autoimmune

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets